Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT05711992
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with rare embryonal tumors of CNS since 01.01.2010:
* ETMR (including embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma (EBL) and medulloepithelioma (MEPL) which were previously classified as CNS-PNETs)
* FOXR2-activated CNS neuroblastoma
* cribriform neuroepithelial tumor
* CNS tumor with BCOR internal tandem duplication
* all patients diagnosed with neuroblastoma and ganglioneuroblastoma with no molecular genetic tests available
* Patients ≤ 25 years of age
* Signed informed consent form for prospective patients ≥ 18 years of age
* Signed parental permission and child assent forms for prospective patients \< 18 years of age
Exclusion Criteria:
• CNS metastases of extracranial embryonal tumors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
25 Years
Study:
NCT05711992
Study Brief:
Protocol Section:
NCT05711992